Focus Stocks
Allergan Closing in to Resistance
Published on Monday, 09 January 2012 19:52 Written by Christopher Lynn
New York, January 9th (TradersHuddle.com) - Shares of Allergan Inc. ( NYSE:AGN) are trading very close to calculated resistance at $88.81 with the current price action closing at just $88.33 placing the stock near levels that make it difficult to buy.
Allergan, Inc. ( NYSE:AGN) is a multi-specialty health care company that develops and commercializes pharmaceuticals, biologics and medical devices. The company develops products for the ophthalmic, neurological, medical aesthetics, breast aesthetics, obesity intervention, urological and other specialty markets in countries around the world.
Allergan's current stock range is defined by current calculated support defined at $78.42 and by the resistance level at $88.81, the stock is clearly over-extended from support, making it difficult to establishing new long positions at this level.
Traders don't have a clear entry point for Allergan, as the stock is well above support, however, as the stock pulls back towards $78.42 it will definitely provide a reference point to establish a trade. On the other hand if the stock decides to break above resistance level at $88.81 then traders will get an opportunity to enter Allergan stock by establishing a position as the stock moves to a higher range.
Related Articles
- Is Allergan Close to Support?
- Allergan Is Dipping Below Support
- Trading Idea: Momentum Building in Allergan
- Allergan Reports First Quarter 2012 Operating Results
- Allergan Is Close to the 50 Day Moving Average
- BOTOX® Cosmetic (onabotulinumtoxinA) Celebrates 10-Year Anniversary of U.S. Food and Drug Administration Approval
- Is Allergan Closing in to Resistance?
- Allergan Is Near its 50 Day Moving Average
- Allergan Announces Quarterly Conference Call
- Allergan Announces Positive Top-Line Results from Phase III BOTOX® Overactive Bladder Program
Related Partner Headlines
- Allergan Stock To Go Ex-dividend Tomorrow (AGN) - TheStreet.com
- Ex-Dividend Stocks: Thomson Reuters, Infosys - TheStreet.com
- Allergan Inc. (AGN): Today's Featured Drugs Winner - TheStreet.com
- Allergan Stock Hits New 52-Week High (AGN) - TheStreet.com
- Signs Point to MAP Pharma Drug Rejection - TheStreet.com
- Allergan Stock Hits New 52-Week High (AGN) - TheStreet.com
- Allergan Stock Hits New 52-Week High (AGN) - TheStreet.com
- Allergan Stock To Go Ex-dividend Tomorrow (AGN) - TheStreet.com
- 9 Ex-Dividend Stocks With Buy Ratings - TheStreet.com
- UPDATE: Morgan Stanley Raises Allergan's PT - Benzinga
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Stocks To Watch For May 25 - Benzinga -
Top 4 Stocks In The Specialty Eateries Industry With The Highest Cash - Benzinga -
Top 4 Small-Cap Stocks In The Security Software & Services Industry With The Highest ROE - Benzinga -
Top 4 Small-Cap Stocks In The Health Care Plans Industry With The Highest Revenue - Benzinga -
Top 4 Small-Cap Stocks In The Heavy Construction Industry With The Lowest PEG Ratio - Benzinga -
Earnings Scheduled For May 25 - Benzinga -
Cramer's 'Mad Money' Recap: Big Government Not Protecting the Little Guys - TheStreet.com -
The Global Retrenchment Accelerates - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
Baxter’s Low Glucose PD Solutions Favorably Impacted Metabolic Measures Including Glycemic Control in Trials of Diabetics Undergoing Dialysis -
Score a Hit With FIFA 13 From Tesco Entertainment Online -
Syngenta settles atrazine litigation in the USA -
Atrazine Litigation Settled -
eMazzanti Attains Xerox Gold Partner Status -
USFS, BLM Hire Youth for Public Lands Conservation Jobs -
SCVBank Elects Scott K. Rushing as New Chairman -
Heritage Oaks Bancorp to Pay Trust Preferred Interest and Accumulated TARP Dividends









